Article
Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis
3 Nov 2008
Abstract excerpt
INTRODUCTION: Treatment with sirolimus, a mammalian target of rapamycin (mTOR) inhibitor, has been shown to be efficacious in the MRL/lpr and NZB x NZW F1 mouse models of lupus nephritis, indicating a critical role for the mTOR pathway in both models. This type of demonstration of efficacy in animal models is usually a pre-requisite for advancement into clinical development. However, efficacy in an animal model...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
